Loading…
CSPC 2022 has ended
Navigating Uncertainty; Targeting Sustainability
Wednesday, November 9 • 4:30pm - 5:30pm
Health Symposium | 675: Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics / 675: Innovation pharmaceutique sociale : des solutions canadiennes pour répondre aux besoins médicaux non satisfa

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics
Innovation pharmaceutique sociale : des solutions canadiennes pour répondre aux besoins médicaux non satisfaits en matière de traitements avancés

Panel Organized by: BioCanRx

Canadians with rare diseases need access to drugs that can help manage and treat their conditions. For those conditions where drugs do exist, costs can be prohibitively high. Well-known national challenges include inconsistent drug access across the country, limitations in drug development and evidence generation linked to small patient populations, and how to achieve the goal of equitable and sustainable access. The panel will discuss the role of social pharmaceutical innovation in Canada’s rare disease strategy and in advancing sustainable access needs both in Canada and internationally, and its potential impact on the academic, public and private sector.

Moderators
avatar for Dr. Durhane Wong-Rieger

Dr. Durhane Wong-Rieger

President & CEO - Canadian Organization for Rare Disorders, Institute for Optimizing Health Outcomes, PhD
She/herPresident & CEO, Canadian Organization for Rare DisordersPresident & CEO, Institute for Optimizing Health OutcomesDurhane Wong-Rieger is President & CEO of the Canadian Organization for Rare Disorders, Chair of the Consumer Advocare Network, President & CEO of the Institute... Read More →

Speakers
avatar for Dr. Risini Weeratna

Dr. Risini Weeratna

Senior Research Officer at the Human Health Therapeutics (HHT) Research Center of the National Research Council Canada (NRC) and leads the Cancer Immunology Team and the cell therapy thrust of the Cell and Gene Therapy Challenge Program
Dr. Risini Weeratna is a Senior Research Officer at the Human Health Therapeutics (HHT) Research Center of the National Research Council Canada (NRC) and leads the Cancer Immunology Team and the cell therapy thrust of the Cell and Gene Therapy Challenge Program. Prior to joining the... Read More →
avatar for Dr. John Bell

Dr. John Bell

Senior Scientist, The Ottawa Hospital | Professor, Depts. Of Medicine and Biochemistry, Microbiology and Immunology, University of Ottawa | Scientific Director, BioCanRx | Director, Canadian Oncolytic Virus Consortium, PhD
He/himDr. John Bell is a world-renowned thought leader in oncolytic virus research and development. In addition to his many academic contributions to the field, Dr. Bell established a GMP manufacturing program that has produced clinical grade oncolytic viruses for worldwide use in... Read More →
avatar for Dr. Boro Dropulic

Dr. Boro Dropulic

Executive Director, Caring Cross, PhD
He/himExecutive Director, Caring CrossBoro received his PhD from the University of Western Australia and his MBA from Johns Hopkins University. After a Fogarty Fellowship at the NIH, he joined the JHU faculty, where he worked on developing Lentiviral vectors as delivery systems for... Read More →
avatar for Dr. Conor Douglas

Dr. Conor Douglas

Associate Professor, Department of Science, Technology and Society, York University, PhD
He/himConor Douglas is an Associate Professor in the Department of Science, Technology and Society within the Faculty of Science at York University. He is an interdisciplinary scholar whose research explores the co-production between science/technology and society; patient and public... Read More →

Wednesday November 9, 2022 4:30pm - 5:30pm EST
Pre-Conference Virtual Zoom Sessions
  Grand Challenges, Health Policy Symposium

Attendees (16)